Stock data
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT) reported net income of -US$328.94M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$333.36M | -US$328.94M | — |
| 2024 | — | — | -US$275.94M | -US$255.86M | — |
| 2023 | — | — | -US$208.13M | -US$192.41M | — |
| 2022 | — | — | -US$147.84M | -US$140.24M | — |
| 2021 | — | — | -US$75.55M | -US$72.27M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$96.41M | — |
| 2026-03-31 | — | -US$97.35M | — |
| 2025-12-31 | — | -US$102.49M | — |
| 2025-09-30 | — | -US$80.93M | — |
| 2025-06-30 | — | -US$73.53M | — |
| 2025-03-31 | — | -US$71.99M | — |
| 2024-12-31 | — | -US$67.93M | — |
| 2024-09-30 | — | -US$70.63M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.